Jane Street’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-151,110
Closed -$521K 13611
2026
Q1
$521K Buy
151,110
+81,179
+116% +$254K ﹤0.01% 7958
2025
Q4
$169K Buy
69,931
+44,716
+177% +$103K ﹤0.01% 9858
2025
Q3
$47.9K Sell
25,215
-80,095
-76% -$147K ﹤0.01% 10366
2025
Q2
$197K Buy
105,310
+78,650
+295% +$137K ﹤0.01% 8563
2025
Q1
$47.5K Buy
+26,660
New +$69.6K ﹤0.01% 9013
2024
Q4
Sell
-25,989
Closed -$53.5K 10879
2024
Q3
$53.5K Sell
25,989
-108,245
-81% -$175K ﹤0.01% 9170
2024
Q2
$196K Buy
+134,234
New +$249K ﹤0.01% 8400
2023
Q4
Sell
-10,630
Closed -$51.4K 9938
2023
Q3
$51.4K Buy
+10,630
New +$61.8K ﹤0.01% 8147
2022
Q2
Sell
-40,233
Closed -$683K 11131
2022
Q1
$683K Buy
+40,233
New +$771K ﹤0.01% 6892
2021
Q2
Sell
-1,039
Closed -$20K 10549
2021
Q1
$20K Sell
1,039
-316
-23% -$7.28K ﹤0.01% 8980
2020
Q4
$20K Buy
1,355
+1
+0.1% +$21 ﹤0.01% 7371
2020
Q3
$30K Buy
+1,354
New +$28.5K ﹤0.01% 6996
2019
Q4
Sell
-2,364
Closed -$24K 5897
2019
Q3
$24K Sell
2,364
-616
-21% -$6.83K ﹤0.01% 4947
2019
Q2
$41K Buy
2,980
+1,987
+200% +$30.1K ﹤0.01% 4976
2019
Q1
$13K Sell
993
-4,473
-82% -$192K ﹤0.01% 4915
2018
Q4
$139K Buy
5,466
+3,738
+216% +$119K ﹤0.01% 4575
2018
Q3
$80K Buy
+1,728
New +$97K ﹤0.01% 4881

Other funds holding WHWK

Jane Street's WHWK Position: Q2 2026 in Review

Jane Street sold out of Whitehawk Therapeutics (WHWK) in Q2 2026, closing a stake of 151,110 shares — an estimated $521K sold.

Jane Street first reported a position in WHWK in Q3 2018 and held it in 17 quarters. The position peaked at $683K in Q1 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Jane Street reported no remaining Whitehawk Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 151,110 Whitehawk Therapeutics shares in Q2 2026, an estimated $521K.
  • Jane Street first reported a position in Whitehawk Therapeutics in Q3 2018 and held it in 17 quarters.
  • Jane Street's Whitehawk Therapeutics position peaked at $683K in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.